Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Innovex International (INVX) Research & Development (2016 - 2024)

Innovex International filings provide 16 years of Research & Development readings, the most recent being $3.6 million for Q2 2024.

  • On a quarterly basis, Research & Development rose 12.05% to $3.6 million in Q2 2024 year-over-year; TTM through Jun 2024 was $13.4 million, a 11.96% increase, with the full-year FY2023 number at $12.6 million, up 7.74% from a year prior.
  • Research & Development hit $3.6 million in Q2 2024 for Innovex International, down from $3.7 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $5.5 million in Q1 2020 to a low of $2.6 million in Q3 2022.
  • Median Research & Development over the past 5 years was $3.6 million (2022), compared with a mean of $3.7 million.
  • Biggest five-year swings in Research & Development: skyrocketed 52.75% in 2020 and later crashed 30.61% in 2021.
  • Innovex International's Research & Development stood at $4.0 million in 2020, then fell by 5.05% to $3.8 million in 2021, then fell by 29.6% to $2.7 million in 2022, then grew by 10.67% to $3.0 million in 2023, then grew by 20.12% to $3.6 million in 2024.
  • The last three reported values for Research & Development were $3.6 million (Q2 2024), $3.7 million (Q1 2024), and $3.0 million (Q4 2023) per Business Quant data.